Clavis Pharma
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 11
- Market Cap
- -
Clinical Study of Previously Untreated Patients With Malignant Melanoma
Phase 2
Completed
- Conditions
- Malignant MelanomaNeoplasm Metastasis
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2007-07-10
- Lead Sponsor
- Clavis Pharma
- Target Recruit Count
- 42
- Registration Number
- NCT00232726
- Locations
- 🇳🇴
The Norwegian Radium Hospital, Oslo, Norway
🇸🇪University Hospital, Lund, Sweden
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath